K162774 is an FDA 510(k) clearance for the MYOtherm XP Cardioplegia Delivery System with Cortiva BioActive Surface, MYOtherm XP Cardioplegia Delivery System with Cortiva BioActive Surface (Bridge System). This device is classified as a Heat-exchanger, Cardiopulmonary Bypass (Class II - Special Controls, product code DTR).
Submitted by Medtronic, Inc. (Mounds View, US). The FDA issued a Cleared decision on February 10, 2017, 130 days after receiving the submission on October 3, 2016.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.4240.